We’re here to decrease the public health threat from COVID-19 and mitigate the pandemic’s economic impact until a vaccine is widely available. A rapid, reliable, inexpensive and easy-to-use at-home antigen test will significantly reduce virus transmission, particularly by asymptomatic patients, while enabling people with negative results to engage in day-to-day activities – from going to work, going to school, shopping, visiting a relative or vacationing. Widespread use of rapid tests is currently limited by the need for trained clinicians or laboratory equipment to ensure that tests are performed and interpreted accurately, the Gauss Rapid At-Home Test can be performed in 15 minutes by an individual, in any location, with a smartphone. Please note, this technology is currently investigational and not authorized or approved by FDA.
The Gauss️ COVID-19 Test Kit includes all the materials necessary to self-administer the test:
a nasal swab, tube with stand, buffer solution, test cassette, a quick guide, and instructions for use.
The smartphone app reads the test results for you, so no additional equipment is needed.
Tube with Stand
Users follow simple step-by-step video instructions in an app to properly collect a nasal swab and complete the rapid test. After 15 minutes, the app prompts the user to scan their test and uses patent-pending, computer vision and artificial intelligence (AI) technology to provide results in seconds. The HIPAA-compliant app securely shares results with the appropriate public health agencies.
In a prospective clinical trial of 219 symptomatic and asymptomatic individuals submitted to the FDA in support of our EUA application, the Gauss Rapid Test demonstrated a 93% Positive Percent Agreement (PPA) and 99% Negative Percent Agreement (NPA) compared to a high-sensitivity, EUA-authorized RT-PCR molecular assay.
QR Scan to Activate
Guided Nasal Swab Collection
Rapid Test Scan
Results in 15 minutes
The Gauss Rapid Antigen Home Test will be made available through various partners and channels, as well as directly from Gauss. Contact us to learn more about partnering with Gauss. This test is currently pending Emergency Use Authorization (EUA) from FDA. The Gauss app is available on the Apple App Store and is already being used by research teams at large academic medical centers to power large-scale, at-home research studies on COVID-19.
Users will be able to scan their test with their smartphone camera about 15 minutes after taking the nasal swab sample and activating the test. The app will then indicate the test result within seconds.
The Gauss at-home rapid antigen test is currently pending Emergency Use Authorization from the FDA. Once authorized, it will be made available through partners such as Kroger Health, Ro, Truepill, as well as directly from Gauss online. Please stay tuned for more information on how to order the test following FDA EUA.